Featured Post

Latest Gold News

Economic power could shift further East with Hong Kong gold exchange Russian investment bank sees $1,400 gold by end of 2017 Weak CPI...

Friday, December 30, 2011

Alexion Pharmaceuticals (ALXN) Ratings, Price Targets

Updates on Alexion Pharmaceuticals (NASDAQ: ALXN) ratings and price targets.

Alexion Pharmaceuticals (NASDAQ: ALXN) had its “Outperform” rating reiterated by Leerink Swann.

Piper Jaffray (NYSE: PJC) cut their price target on Alexion Pharmaceuticals to $83.00.

Barclays Capital (NYSE: BCS) initiated coverage on Alexion Pharmaceuticals. They placed an “Overweight” rating and a price target of $77.00 on the company.

Morgan Stanley (NYSE: MS) raised their price target on Alexion Pharmaceuticals to $67.00 on October 24th.

Alexion closed Thursday at $70.98, up $0.06, or 0.08 percent.

No comments: